U.S. scientists said they have devised a noninvasive blood test that can accurately detect Down syndrome as well as other chromosomal disorders such as Edward and Patau syndromes in unborn infants. The test, which could be on the market in two to three years, could help eliminate the need for invasive testing methods such as amniocentesis and chorionic villus sampling, the lead researcher said.

Full Story:

Related Summaries